e-Drug3D

580

MISOPROSTOL


INN
MISOPROSTOL

(has an active metabolite)

cas 59122-46-2
CLASS

METABOLISM
ANTIULCERATIVE
PROSTAGLANDINS
SYNTHETIC PROSTAGLANDIN E1 ANALOG

ROUTE (list)

ORAL

ATC code

A02BB01
G02AD06
M01AE56

PK parameters

Solubility

SOLUBLE IN WATER


Target

TARGET PROSTAGLANDIN RECEPTOR

DrugCentral

Prostaglandin E2 receptor EP3 subtype UNIPROT P43115 PTGER3

Download SDF file methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate

Formula:
C22H38O5

Calculated chemical properties:

MW 382.52
NB_atoms 27
XLogP 3.95
PSA 83.23
NB_HD 2
NB_HA 5
fsp3 0.82
Lipinski(0=no;1=yes) 1

FDA
NDA 019268 (pdf not found) INN (MISOPROSTOL) CYTOTEC (PFIZER) APPROVAL= AP YEAR= 1988
NDA 020607 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) ARTHROTEC (PFIZER) APPROVAL= AP YEAR= 1997
NDA 076095 (pdf not found) INN (MISOPROSTOL) MISOPROSTOL (ANI PHARMS) APPROVAL= AP YEAR= 2002
NDA 091667 (pdf not found) INN (MISOPROSTOL) MISOPROSTOL (NOVEL LABS INC) APPROVAL= AP YEAR= 2012 DISCONTINUED
NDA 201089 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2012
NDA 200158 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (SANDOZ) APPROVAL= AP YEAR= 2013
NDA 200540 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (EXELA HOLDINGS) APPROVAL= AP YEAR= 2014 DISCONTINUED
NDA 203995 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (AMNEAL PHARMS) APPROVAL= AP YEAR= 2016
NDA 210201 (pdf not found) INN (MISOPROSTOL) MISOPROSTOL (ACQ PHARMA) APPROVAL= AP YEAR= 2019
NDA 205143 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (YUNG SHIN PHARM) APPROVAL= AP YEAR= 2020
NDA 204355 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (MICRO LABS) APPROVAL= AP YEAR= 2021
NDA 216872 (pdf not found) INN (MISOPROSTOL) MISOPROSTOL (MICRO LABS) APPROVAL= AP YEAR= 2022
NDA 206771 (pdf not found) INN (DICLOFENAC SODIUM ; MISOPROSTOL) DICLOFENAC SODIUM AND MISOPROSTOL (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL